Free Trial

Neoleukin Therapeutics (NLTX) SEC Filings & 10K Form

Neoleukin Therapeutics logo
$10.46 +0.81 (+8.34%)
As of 04/2/2025

Recent Neoleukin Therapeutics SEC Filings

DateFilerForm TypeView
04/01/2025
4:22 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 424B3
03/30/2025
11:15 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form EFFECT
03/28/2025
8:27 PM
McMinn Rachel (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
8:28 PM
Jordan Julie (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
8:29 PM
Cvijic Christine Mikail (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
8:30 PM
Cobb Stuart (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:30 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/24/2025
3:32 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form POS AM
03/24/2025
3:34 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/24/2025
3:14 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
4:14 PM
Cvijic Christine Mikail (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
7:01 PM
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Redmile Group, LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
10:34 AM
JANUS HENDERSON GROUP PLC (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SCHEDULE 13G/A
02/14/2025
8:00 AM
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
01/13/2025
6:30 AM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
3:01 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 424B3
12/16/2024
11:15 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form EFFECT
12/11/2024
3:05 PM
COMMODORE CAPITAL LP (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SC 13G
12/02/2024
4:27 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/27/2024
3:36 PM
AKKARAJU SRINIVAS (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/25/2024
8:29 PM
McMinn Rachel (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
8:29 PM
Cvijic Christine Mikail (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:01 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
4:26 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
4:27 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/18/2024
5:50 AM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:53 PM
GREAT POINT PARTNERS LLC (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SC 13G/A
11/14/2024
2:24 PM
JANUS HENDERSON GROUP PLC (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SC 13G/A
11/14/2024
2:05 PM
Cormorant Asset Management, LP (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SC 13G/A
11/14/2024
5:22 AM
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
11/04/2024
6:33 AM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
3:15 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
6:31 AM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
6:31 AM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
3:36 PM
BlackRock Inc. (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SC 13G
06/21/2024
7:32 AM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
1:11 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
1:35 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
1:35 PM
Freedland Cory S. (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
1:36 PM
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Noonberg Sarah B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
1:36 PM
BAFFI ROBERT (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Your Retirement Is Caught in the Crossfire (Ad)

When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.

Go Here to Learn What's Happening and How to Prepare >>
06/17/2024
1:37 PM
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
PALEKAR ROHAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
1:37 PM
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Woods Robert Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
6:31 AM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
6:31 AM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
5:20 AM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
1:33 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form DEF 14A
04/26/2024
1:33 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form ARS
04/26/2024
1:34 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form DEFA14A
04/22/2024
3:44 PM
Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:NLTX) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners